830 Heinz Avenue
Berkeley, CA 94710
Pathway-specific Therapeutics and Diagnostics for Alzheimer’s disease
Recent discoveries in biomimetic chemistry have enabled highly effective new approaches to definitively isolate the cause of disease and directly link gene-epitope-antibody relationships for systematically stratified immunotherapeutics.
To learn more about how Anven Biosciences and our “proxy antigen” technology can help you develop effective treatments for Alzheimer’s and other neurodegenerative diseases, please contact us: